Vimarsana
Biggest News Aggregation in the World

Nucl Med News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nucl Med. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nucl Med Today - Breaking & Trending Today

Ferronova and Purdue Research Foundation (PRF) Sign Licensing Agreement for Use of Fibroblast Activation Protein (FAP) Inhibitor in Radiotherapy - Vimarsana News

Ferronova and Purdue Research Foundation (PRF) Sign Licensing Agreement for Use of Fibroblast Activation Protein (FAP) Inhibitor in Radiotherapy

ADELAIDE, Australia--(BUSINESS WIRE)--Australian biotech company Ferronova announced today that it has signed a licensing agreement with the Purdue Research Foundation (PRF) for the application of

GE HealthCare Announces FES PET Imaging Recommendation in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) - Vimarsana News

GE HealthCare Announces FES PET Imaging Recommendation in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)

In March 2023, Appropriate Use Criteria (AUC) for ER-targeted PET imaging was also published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI)

GE HealthCare Announces FES PET Imaging Recommendation in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) - Vimarsana News

GE HealthCare Announces FES PET Imaging Recommendation in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)

NCCN Guidelines® for clinicians and patients now recommend the use of FES PET for ER+ positive disease under certain circumstances during the systemic staging workup of patients with recurrent... | May 24, 2023

Telix Pharmaceuticals Limited: Telix Accelerates Artificial Intelligence (AI) Development Program with Acquisition of Dedicaid - Vimarsana News

Telix Pharmaceuticals Limited: Telix Accelerates Artificial Intelligence (AI) Development Program with Acquisition of Dedicaid

MELBOURNE, Australia, April 26, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the expansion of its artificial intelligence (AI) capability

Telix Accelerates Artificial Intelligence (AI) Development Program with Acquisition of Dedicaid - Vimarsana News

Telix Accelerates Artificial Intelligence (AI) Development Program with Acquisition of Dedicaid

MELBOURNE, Australia, April 27, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the expansion of its...